These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2568936)

  • 1. [3H]SCH 23390 labels dopamine D-1 receptor sites in the rat kidney.
    Zdilar D; Lacković Z
    Eur J Pharmacol; 1989 May; 164(1):159-62. PubMed ID: 2568936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of SCH 23390-induced alteration of striatal dopamine D1 receptor ontogeny by prolyl-leucyl-glycinamide in the rat.
    Kostrzewa RM; Saleh MI
    Neuropharmacology; 1989 Aug; 28(8):805-10. PubMed ID: 2571103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat.
    Apud JA; Masotto C; Ongini E; Racagni G
    Eur J Pharmacol; 1985 Jun; 112(2):187-93. PubMed ID: 2863153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated administration of (-)sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions.
    Memo M; Pizzi M; Nisoli E; Missale C; Carruba MO; Spano P
    Eur J Pharmacol; 1987 Jun; 138(1):45-51. PubMed ID: 2887436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390.
    Hyttel J
    Neuropharmacology; 1984 Dec; 23(12A):1395-401. PubMed ID: 6152023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]SCH 23390 labels a novel 5-hydroxytryptamine binding site in human blood platelet membranes.
    De Keyser J; Walraevens H; Convents A; Ebinger G; Vauquelin G
    Eur J Pharmacol; 1989 Mar; 162(3):437-45. PubMed ID: 2568263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain.
    Andersen PH
    Eur J Pharmacol; 1988 Jan; 146(1):113-20. PubMed ID: 2895008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors.
    Porceddu ML; Ongini E; Biggio G
    Eur J Pharmacol; 1985 Dec; 118(3):367-70. PubMed ID: 2935413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of [3H]SCH 23390 to dopamine D-1 receptors in rat retina in vitro.
    Gredal O; Parkinson D; Nielsen M
    Eur J Pharmacol; 1987 Jun; 137(2-3):241-5. PubMed ID: 2886353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoradiographic localization of dopamine DA1 receptors in rat kidney with [3H]Sch 23390.
    Huo T; Healy DP
    Am J Physiol; 1989 Sep; 257(3 Pt 2):F414-23. PubMed ID: 2528915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural determinants of selective affinity for brain D-1 dopamine receptors within a series of 1-phenyl-1H-3-benzazepine analogues of SK&F 38393 and SCH 23390.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1985 Sep; 115(2-3):291-5. PubMed ID: 2866103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]SCH 23390 identifies D-1 binding sites in rat striatum and other brain areas.
    Kilpatrick GJ; Jenner P; Marsden CD
    J Pharm Pharmacol; 1986 Dec; 38(12):907-12. PubMed ID: 2880965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the effects of SKF 82526 and LY 171555 on presynaptic (DA2) and postsynaptic (DA1) dopamine receptors in rat kidney.
    Lokhandwala MF; Steenberg ML
    J Auton Pharmacol; 1984 Dec; 4(4):273-7. PubMed ID: 6152269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics.
    Meller E; Bohmaker K; Goldstein M; Friedhoff AJ
    J Pharmacol Exp Ther; 1985 Jun; 233(3):656-62. PubMed ID: 2861276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of SCH 23390, YM 09151-2, (+)- and (-)-3-PPP and some classical neuroleptics on D-1 and D-2 receptors in rat neostriatum in vitro.
    Plantjé JF; Hansen HA; Daus FJ; Stoof JC
    Eur J Pharmacol; 1984 Oct; 105(1-2):73-83. PubMed ID: 6208045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [125I]SCH 23982: the ligand of choice for identifying the D-1 dopamine receptor.
    Sidhu A; van Oene JC; Dandridge P; Kaiser C; Kebabian JW
    Eur J Pharmacol; 1986 Sep; 128(3):213-20. PubMed ID: 2947806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
    Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
    Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
    Faedda G; Kula NS; Baldessarini RJ
    Biochem Pharmacol; 1989 Feb; 38(3):473-80. PubMed ID: 2563653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemical basis for the blockade of the D-1 dopamine receptor by SCH 23390.
    Itoh Y; Beaulieu M; Kebabian JW
    Eur J Pharmacol; 1984 Apr; 100(1):119-22. PubMed ID: 6144550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.